Dennis M McGrath
CIK 1269340 · President and CFO · last filed 2026-09-28
Dennis M McGrath is a President and CFO who has filed 69 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for DRIO, was dated Sep 28, 2026. Across all open-market trades the lifetime net is −$3.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.1M across reported positions. 15 SEC filings were submitted jointly with PAVmed Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PHMD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE GRAND CENTRAL PLACE, STE. 4600
NEW YORK, NY 10165
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DRIO | Director | 88,737 | $3.40 | $301.7K | -$1.19M | 7 | 2026-09-28 |
| PAVM | President and CFO | 186,695 | $2.26 | $421.9K | $0 | 2 | 2026-04-03 |
| LUCD | Chief Financial Officer | 1,813,569 | $0.50 | $908.1K | $0 | 5 | 2026-02-24 |
| CTOR | Director | 300,000 | $0.60 | $178.7K | $0 | 4 | 2025-12-22 |
| CTXR | Director | — | $0.45 | — | $0 | 3 | 2024-11-12 |
| PAVmed Inc. (PAVMZ) Delisted | President & CFO | 755,489 | $0.00 | $680 | $5.4K | 6 | 2022-04-11 |
| DarioHealth Corp. (DRIOW) Delisted | Director | 97,403 | — | — | $0 | 19 | 2021-01-21 |
| PAVmed Inc. (PAVMW) Delisted | EVP & CFO | 10,500 | $0.03 | $304 | $50.2K | 5 | 2018-02-16 |
| ARRY | Director | 1,029,238 | $3.15 | $3.24M | $0 | 2 | 2017-12-28 |
| DarioHealth Corp. (DRIO.W) Delisted | Director | 11,820 | — | — | $0 | 1 | 2016-08-17 |
| FC Global Realty Inc (PHMD) Delisted | President & CFO | 51,227 | — | — | -$2.45M | 13 | 2014-12-16 |
| FC Global Realty Inc (PHMDD) Delisted | CFO & VP Finance | 79,428 | — | — | $0 | 1 | 2009-07-13 |
Recent Filings
69 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-28 | DRIO | Grant (A) | +61,000 | $0 | EDGAR |
| 2026-04-03 | PAVM | Grant (A) | +180,000 | $0 | EDGAR |
| 2026-02-24 | LUCD | Grant (A) | +470,000 | $0 | EDGAR |
| 2025-12-22 | CTOR | Grant (A) | +300,000 | $0 | EDGAR |
| 2025-12-01 | CTOR | Grant (A) | +300,000 | $0 | EDGAR |
| 2025-10-02 | PAVM | Grant (A) | +150,000 | $0 | EDGAR |
| 2025-09-23 | CTOR | Grant (A) | +300,000 | $0 | EDGAR |
| 2025-09-15 | DRIO | Grant (A) | +20,000 | $0 | EDGAR |
| 2025-02-21 | LUCD | Grant (A) | +300,000 | $0 | EDGAR |
| 2024-12-16 | CTOR | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.